Jill M. Quigley

Insider Reports History

Identity 1 identity field
Location
Philadelphia, PA
SEC source record 1 source field
Owner filing signature
/s/ David Strauss, as Attorney-in-Fact for Jill M. Quigley
Source evidence 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jill M. Quigley

Form 4 holding Chief Operating Officer

Passage BIO, Inc.

Security class
Common Stock
Shares / value
368,754
Estimated value
$335,566
Report date
08 Dec 2021
Price
$0.9100
Ownership
Direct
Form 4 holding Chief Operating Officer

Passage BIO, Inc.

Security class
Common Stock
Shares / value
3,608
Estimated value
$3,283
Report date
08 Dec 2021
Price
$0.9100
Ownership
By Spouse
Form 4 holding Chief Operating Officer

Passage BIO, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
27,626
Estimated value
Report date
08 Dec 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Chemomab Therapeutics Ltd.

Security class
Option to Purchase American Depositary Shares
Shares / value
13,640
Estimated value
Report date
16 Jun 2022
Price
Ownership
Direct
Underlying class
American Depositary Shares
Underlying amount

Insider Reports Filed by Jill M. Quigley

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .